Visual rating and ROI-based parametric analysis of rCBF SPECT in patients with mild or questionable dementia: A comparative study

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 6, 2007, Pages 429-433

  Høgh, Peter ^a   Teller, Ann Sofie ^a   Hasselbalch, Steen ^a   Waldemar, Gunhild ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

Dementia; Mild cognitive impairment; Parametric; SPECT; Visual rating

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VISUAL PERCEPTION;

EID: 36448946905     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110023     Document Type: Article

References (26)

1. Hejl A, Høgh P, Waldemar G: Potentially reversible conditions in 1,000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry 2002;73:390-394.
2. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
3. Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M: Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007;14:e1-e26.
4. 99mTc]-d,l-HMPAO SPECT study. J Neurol Neurosurg Psychiatry 1994;57:285-295.
5. Masdeu JC, Brass LM, Holman BL, Kushner MJ: Brain single photon emission computed tomography. Neurology 1994;44:1970-1977.
6. Jagust WJ, Johnson KA, Holman BL: SPECT perfusion imaging in the diagnosis of dementia. J Neuroimaging 1995;5:545-552.
7. Talbot PR, Testa HJ: The value of SPECT imaging in dementia. Nucl Med Commun 1995;16:425-437.
8. Coleman RE: Positron emission tomography diagnosis of Alzheimer's disease (review). Neuroimaging Clin N Am 2005;15:837-846.
9. Coimbra A, Williams DS, Hostetler ED: The role of MRI and PET/SPECT in Alzheimer's disease (review). Curr Top Med Chem 2006;6:629-647.
10. Korf ES, Wahlund LO, Visser PJ, Scheltens P: Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004;63:94-100.
11. 99mTc-bicisate (neurolite) SPECT brain imaging and cognitive impairment in dementia of the Alzheimer type: a blinded read of image sets from a multicenter SPECT trial. J Cereb Blood Flow Metab 1994;14:99-105.
12. Folstein MF, Folstein SE, McHugh PR: Minimental state: a practical method for grading the cognitive state of patient for the clinician. J Psychiatr Res 1975;12:189-198.
13. Waldemar G, Bruhn P, Schmidt E, et al: Cognitive profiles and regional cerebral blood flow patterns in dementia of the Alzheimer type. Eur J Neurol 1994;1:81-89.
14. Høgh P, Knudsen GM, Kjaer KH, Jørgensen OS, Paulson OB, Waldemar G: Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow. J Geriatr Psychiatry Neurol 2001;14:42-51.
15. Waldemar G, Hasselbalch SG, Andersen AR, Delecluse F, Petersen P, Johnsen A, Paulson OB: 99mTc-d,l-HMPAO and SPECT of the brain in normal aging. J Cereb Blood Flow Metab 1991;11:508-521.
16. Lee YC, Liu RS, Liao YC, Wang PN, Lin KN, Liu HC: Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease. Eur Neurol 2004;52:142-149.
17. Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, Grassi F, Bettinardi V, Frackowiak AS, Fazio F: Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage 1999;9:63-80.
18. SPM Central: Statistical Parametric Mapping. 2004. http://www.fil.ion. ucl.ac.uk/spm.
19. Van Laere KJ, Warwick J, Versijpt J, Goethals I, Audenaert K, Van Heerden B, Dierckx R: Analysis of clinical brain SPECT data based on anatomic standardization and reference to normal data: an ROC-based comparison of visual, semiquantitative and voxel-based methods. J Nucl Med 2002;43:458-469.
20. 18F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med 2002;43:1167-1174.
21. 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage 2004;23:956-966.
22. Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE: Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 1995;36:1141-1149.
23. Silverman DH, Small GW, Chang CY, et al: Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 2001;286:2120-2127.
24. Pasquier F, Lavenu I, Lebert F, Jacob B, Pruvo JP, Petit H: The use of SPECT in a multidisciplinary memory clinic. Dement Geriatr Cogn Disord 1997;8:85-91.
25. Staffen W, Schonauer U, Zauner H, Spindler I, Mair A, Iglseder B, Bernroider G, Ladumer G: Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation. J Neural Transm 2006;113:195-203.
26. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-746.